Fatigue News and Research

RSS

NICE promotes use of dual-chamber pacemakers for treating bradycardia

In new medical guidance for England and Wales published today, the National Institute for Clinical Excellence (NICE) promotes the expanded use of dual-chamber pacemakers for treating slow heart rhythms, called bradycardia, which affect an estimated 100,000 people in the UK.

23 Feb 2005

Exercise therapy can improve muscle strength in people with multiple sclerosis

Exercise therapy also improved the mood of MS patients in exercise therapy programs, compared to patients who did not participate in the therapy. The researchers did not find any evidence that exercise therapy affected patients’ fatigue or their sense of how ill they were.

22 Feb 2005

Early diagnosis and treatment is important for children and adolescents with bipolar disorder

"These new guidelines were formulated by a group of leading experts in child psychiatry and are the most up-to-date and comprehensive set of guidelines for the treatment of children and adolescents with bipolar disorder," said Dr. Kowatch. "They represent a major step towards practicing evidence-based medicine in this difficult to treat group of patients.

22 Feb 2005

Lack of magnesium in diet linked to disease

The Gordon Research International Conference on Magnesium was held during the second week in February in Ventura, California, to discuss the research findings on the links between deficiencies in the mineral magnesium and a host of life-threatening diseases, including heart disease and arteriosclerosis.

22 Feb 2005

82 percent of women have at least one factor that puts them at risk for a future heart attack

In the second year of a Northern California-based survey conducted by Sutter Health on women and heart disease, results show that more women are aware of heart attack warning signs and the need to take action quickly.

21 Feb 2005

Nonsurgical microspheres an option for liver cancer patients

A study in February’s Journal of Vascular and Interventional Radiology found that patients undergoing liver cancer treatment with Theraspheres?, radioactive microspheres containing Yittrium-90, can tolerate a 150 Gy single dose or 268 Gy repeated dose without risk of radiation-induced liver disease.

17 Feb 2005

Scientists show knocking out key signals will cause diabetes

Using a revolutionary technique to turn off chemical signals inside the cell, scientists at Joslin Diabetes Center have discovered that the different metabolic abnormalities present in type 2 diabetes can be caused by knocking out two key signals in liver cells.

11 Feb 2005

Suffering from fatigue, abdominal discomfort or bloody diarrhea? Your doctor might not recommend an uncomfortable endoscopy

People living with fatigue, abdominal discomfort and bloody diarrhea caused by the chronic inflammation of ulcerative colitis may no longer need to undergo frequent and uncomfortable endoscopies, a new study shows.

3 Feb 2005

World-first advertising campaign warns women about the health impacts, and ineffectiveness, of fad diets

A world-first advertising campaign that warns women about the health impacts, and ineffectiveness, of fad diets has been launched by the Australian Health Minister, Bronwyn Pike.

18 Jan 2005

Lifting weights can help people with multiple sclerosis

Lifting weights can improve muscle strength and quality of life for people afflicted with the degenerative disease multiple sclerosis, a new University of Florida study finds.

17 Jan 2005

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.

17 Jan 2005

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Millennium Pharmaceuticals today announced, in collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, the initiation of VISTA (Velcadeas Initial Standard Therapy in multiple myeloma: Assessment with melphalan and prednisone), a multicenter, international phase III clinical trial of Velcadein combination with melphalan and prednisone versus melphalan and prednisone in patients with newly diagnosed multiple myeloma (MM) who are not transplant candidates.

10 Jan 2005

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

7 Jan 2005

European approval of Cymbalta/Xeristar for treatment of major depressive episodes

Eli Lilly and Company and Boehringer Ingelheim announced today that Cymbalta/Xeristar (duloxetine hydrochloride)(+) has been granted marketing authorization by the European Commission for the treatment of major depressive episodes.

5 Jan 2005

Stem cells from umbilical cord blood effectively treated heart attacks

When injected into rats' hearts soon after a heart attack, stem cells taken from human umbilical cord blood (HUCB) greatly reduced the size of heart damage and restored pumping function to near normal. This improvement occurred without the need for drugs to prevent the rats' immune system from rejecting the human cells.

5 Jan 2005

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Vaccinating large populations of white-footed mice against the bacterium that causes Lyme disease could help reduce the risk of transmission of the disease to humans, says a study supported by the National Institute of Allergy and Infectious Diseases (NIAID).

14 Dec 2004

M.E. emerges from the wilderness

In 1955 medical literature first defined and described M.E., an illness that had probably been with us for hundreds of years. But with a wide range of symptoms, no diagnostic test and much misunderstanding about its cause, people with M.E. often had to struggle to manage the illness with little support from specialist services.

14 Dec 2004

Key molecular signal allows malarial parasites to target human red blood cells

Northwestern University researchers have identified a key molecular "signal" that allows malarial parasites to release virulence proteins inside human red blood cells.

13 Dec 2004

Clinical care of community-dwelling older adults with advanced chronic diseases would be enhanced by identifying and alleviating the range of symptoms they experience

In a study to determine the prevalence of a range of symptoms among older persons living independently with advanced chronic diseases, researchers at Yale have found that the majority experienced multiple moderate or severe symptoms.

8 Dec 2004

New advances in sickle cell disease

Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.

6 Dec 2004

Fatigue News and Research

NICE promotes use of dual-chamber pacemakers for treating bradycardia

Exercise therapy can improve muscle strength in people with multiple sclerosis

Early diagnosis and treatment is important for children and adolescents with bipolar disorder

Lack of magnesium in diet linked to disease

82 percent of women have at least one factor that puts them at risk for a future heart attack

Nonsurgical microspheres an option for liver cancer patients

Scientists show knocking out key signals will cause diabetes

Suffering from fatigue, abdominal discomfort or bloody diarrhea? Your doctor might not recommend an uncomfortable endoscopy

World-first advertising campaign warns women about the health impacts, and ineffectiveness, of fad diets

Lifting weights can help people with multiple sclerosis

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

European approval of Cymbalta/Xeristar for treatment of major depressive episodes

Stem cells from umbilical cord blood effectively treated heart attacks

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

M.E. emerges from the wilderness

Key molecular signal allows malarial parasites to target human red blood cells

Clinical care of community-dwelling older adults with advanced chronic diseases would be enhanced by identifying and alleviating the range of symptoms they experience

New advances in sickle cell disease

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News